Sai Parenteral’s IPO Allotment Status Online

The Sai Parenteral’s IPO allotment status will be available on the allotment date on March 30, 2026, Monday. The Sai Parenteral’s IPO subscription was ended on March 27, 2026, Friday.

The investors who applied for the IPO will be able to check the Sai Parenteral’s IPO allotment status online on the Bigshare Services Pvt. Ltd. website or the BSE, NSE website. The IPO was subscribed [.] times overall. The IPO GMP went around ₹0 level after the subscription ended.

Sai Parenteral’s IPO

Sai Parenteral’s IPO Allotment Date

As per the timeline, the Sai Parenteral’s IPO allotment date is March 30, 2026, Monday. The investors can check the IPO allotment via the registrar website of Bigshare or the BSE, NSE website. Investors can check the allotment status online and offline with easy steps given below:

Registrar:Bigshare IPO Allotment Page
BSE: BSE IPO Allotment Page
NSE: NSE IPO Allotment Page
IPO Watch:IPO Allotment Status Page

Check Sai Parenteral’s’ IPO Allotment Status on Registrar site?

  1. Visit Bigshare Services Pvt. Ltd. website
  2. Select IPO Name ‘Sai Parenteral’s’ from the drop-down menu on the page
  3. Enter details required like PAN Card, Application Number, or Demat Account Number
  4. Click on the ‘Search’ Button, and;
  5. Get your allotment on the your screen

Check Sai Parenteral’s IPO Allotment Status on BSE?

  1. Visit BSE India IPO Allotment Page
  2. Select the issue type: equity/debt
  3. Select IPO Name ‘Sai Parenteral’s’ from the drop-down menu on the page
  4. Enter details required like PAN Card or Application Number
  5. Click on the ‘Search’ Button, and;
  6. Get your allotment on the your screen

Check Sai Parenteral’s IPO Allotment Status on NSE?

  1. Visit NSE India IPO Allotment Page
  2. Select the issue type
  3. Select IPO Name ‘Sai Parenteral’s’ from the drop-down menu on the page
  4. Enter details required like PAN Card or Application Number
  5. Click on the ‘Search’ Button, and;
  6. Get your allotment on the your screen

IPO Subscription Details

CategoryDay 1Day 2Day 3
QIB
NII
RII
Total

Sai Parenteral’s IPO Key Dates

IPO Open Date:March 24, 2026
IPO Close Date:March 27, 2026
Basis of Allotment:March 30, 2026
Refunds:April 1, 2026
Credit to Demat Account:April 1, 2026
IPO Listing Date:April 2, 2026

Business Overview

Sai Parenteral’s Ltd., founded in 2001, is one of the leading pharmaceutical companies focused on R&D and manufacturing of pharmaceutical products. The firm operates in 2 main business areas: makes and sells its own branded medicines, and also manufactures medicines for other companies internationally. Its product offerings include a wide range of medicines for various health conditions, like cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals, and supplements (VMS), analgesics, and dermatology.

Its medicines are available in various forms like tablets, injections, and syrups. Sai Parenteral’s major clients are government agencies, pharmaceutical companies, public and private hospitals, and large distributors in India. The firm operates 5 manufacturing facilities in India, mainly located in Hyderabad, known for developing medicines with international quality certifications.

Note for the Investors

Sai Parenteral’s IPO Registrar is responsible for the IPO allotment and refund process. If you have any queries regarding the Sai Parenteral’s IPO Allotment date and time please contact the registrar with your queries.

Sai Parenteral’s IPO Allotment Status FAQs


When is Sai Parenteral’s IPO Allotment Date?

Sai Parenteral’s IPO Allotment is to be available on March 30, 2026, Monday.

What will be Sai Parenteral’s IPO Refund Date?

The IPO refund date is April 1, 2026, Wednesday.

How to check the Sai Parenteral’s IPO Allotment Status?

Check Sai Parenteral’s IPO allotment status via your PAN number, the application number, or the amount deducted in your bank.

Table of Contents

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *